Show summary Hide summary
Kate Middleton made her debut in an unexpected designer on June 2, wearing Rodarte to a Cancer Research UK 125th anniversary reception at St. James’s Palace in London. The Princess of Wales joined King Charles III and Queen Camilla to celebrate the milestone of the world’s largest independent cancer research organization—a cause deeply personal to both royals, who announced cancer diagnoses within weeks of each other in 2024.
Quick Facts
- First Rodarte appearance: Kate wore a red silk twill heart-print midi dress by the Los Angeles-based label, marking her debut in the brand
- The milestone: Cancer Research UK marked 125 years of work in cancer prevention, diagnosis, and treatment
- Joint appearance: Kate and King Charles attended together, their first joint public outing in support of a cause personal to both
- Remission: Kate announced she was in remission in January 2025 after completing preventative chemotherapy in fall 2024
A Bold Choice for a Meaningful Moment
The dress itself—a printed silk twill midi in red with a delicate heart pattern, featuring a belted waist and contrasting collar—represents a notable shift in Kate’s recent styling. Known for repeating outfits at engagements, she opted for a new-to-her designer, signaling the importance of the occasion. The Pasadena-based label Rodarte, overseen by California sisters Kate and Laura Mulleavy, is celebrated for romantic silhouettes and art historical references. Kate paired the dress with her signature red Gianvito Rossi suede heels, a ruby pendant necklace, ruby and diamond earrings, and a Miu Miu red clutch—a cohesive, striking look in her favorite color and pattern.
A Shared Cause and Personal Connection
The reception marked the first time Kate and King Charles have jointly supported a cause that touches both their lives. In 2024, both announced cancer diagnoses within weeks of each other. King Charles became the primary patron of Cancer Research UK following his diagnosis and continues undergoing treatment for an unspecified cancer. Kate announced she was in remission in January 2025, stating: “As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal. I am however looking forward to a fulfilling year ahead.” According to Buckingham Palace, Cancer Research UK “has helped to transform how cancer is understood, prevented, detected and treated. This progress has contributed to a doubling of cancer survival in the UK over the past 50 years and today 8 in 10 people who receive cancer drugs in the UK receive a drug developed by or with Cancer Research UK.”
Kate Middleton wears unexpected Rodarte designer to honor Cancer Research UK milestone
Paul Rudd’s box office flop ‘Death of a Unicorn’ becomes HBO Max hit
Why the Dress Matters
Kate’s choice to debut a new designer at this reception underscores her commitment to the charity’s mission. The heart print—a subtle but deliberate detail—carries symbolic weight for a cancer research organization and reflects the emotional stakes of the cause. Her willingness to step outside her usual designer rotation signals that this moment warranted something fresh and intentional. The silk heart-print dress has since become widely discussed in fashion circles, with outlets noting how the romantic aesthetic aligns with both Rodarte’s signature style and the gravity of honoring 125 years of cancer research and treatment breakthroughs that have saved countless lives across the UK and beyond.
Sources
- Town & Country Magazine — Detailed reporting on Kate’s Rodarte dress, styling, and the reception’s significance
- Vogue — Context on Rodarte’s design philosophy, Kate’s cancer journey, and the joint appearance with King Charles
- HELLO! Magazine — Coverage of Kate’s support for the Cancer Research UK milestone
- AOL / Associated Press — Confirmation of both royals’ 2024 cancer diagnoses and remission status
